VWING is a commercially-pure titanium needle guide that is sutured onto the AV fistula by a vascular surgeon; the innovative guide makes hemodialysis access a safe, reliable, and easier experience for the patient
Given its success in lowering infection rates, vascular aneurysms, and associated costs, VWING is poised to become the “standard of care” for difficult-to-cannulate arteriovenous (AV) fistulas. VWING key benefits include the minimization of complications, and reduction of catheter days, which can ultimately decrease costs in the critically important hemodialysis market
Value Provided by Frontcourt
Engaged by Deerfield Asset Management to auction off Vital Access assets
Created Confidential Information Memorandum and summary overview deck
Completed a comprehensive competitive analysis
Conducted thorough due diligence including attending key industry conferences and events to formulate the strategy
Identified and coordinated with industry KOLs to support and endorse our process and approach
Conducted auction and interacted with dozens of potential buyers
Negotiated terms with potential bidders
Presented the seller with options and recommendation
Facilitated confirmatory buyer due diligence
Completed Sale transaction to Asia-based MedTech Company
